Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Metethoheptazine
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Other names | WY-535 |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C17H25NO2 |
Molar mass | 275.392 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Metethoheptazine (WY-535) is an opioid analgesic from the phenazepine family. It was invented in the 1960s.
Metethoheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.
Metethoheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States. The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.